Recent Articles from Investor Brand Network

Wearable Devices (NASDAQ: WLDS) announced the launch of Mudra Pro for early pre-orders, offering OEMs, enterprise innovation teams, researchers and developers access to product specifications, software development kit capabilities and pilot program resources. Developed through the company’s ai6 Labs initiative, the AI-powered neural wristband features a thinner ergonomic design and adds a photoplethysmography sensor alongside electromyography and inertial measurement unit sensors, expanding sensing capabilities for cardiovascular monitoring, gesture recognition and intent-based interfaces while helping customers accelerate development and commercialization efforts.

Exploring the policies, markets and global events influencing currencies and the movement of money worldwide

Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently announced that it is set to join both the broad-market Russell 3000(R) Index and the small-cap Russell 2000(R) Index ( https://ibn.fm/KcXh1 ).

LiveOne (NASDAQ: LVO) received a vote of confidence from Roth Capital Partners following the company’s newly announced collaboration with AT&T and Cisco, which will make LiveOne’s audio streaming services available through AT&T’s Connected Car ecosystem. In a June 4 research note, Roth Managing Director and Senior Research Analyst Sean McGowan maintained a Buy rating and $14 price target, describing the agreement as another major addition to LiveOne’s expanding roster of B2B partnerships. The analyst noted that the company has spent more than a year pursuing large-scale partnerships across multiple industries and characterized the AT&T deal as one of its most significant to date.

The disruption of global oil supplies following the Strait of Hormuz closure has pushed energy costs higher across every sector, including food. Modern food systems consume up to 30% of global oil supplies, making the fossil fuel integral to the agricultural sector.

Companies making AI chips have registered a major rally in the prices of their shares, and this has added momentum to the growing debates about whether or not these surges are fueling an AI bubble that could burst anytime.

Oncotelic Therapeutics (OTCQB: OTLC) announced its placement in a BioMedWire editorial examining growing investor interest in platform biotech companies as the global drug-delivery market advances toward an estimated $410 billion opportunity. The editorial highlights increasing industry focus on overcoming challenges related to drug penetration, tumor targeting, therapeutic resistance and maintaining consistent intratumoral exposure, while spotlighting Oncotelic’s Sapu003 and Deciparticle platform as examples of nanotechnology-driven drug-delivery approaches designed to enhance the clinical utility of existing therapies through improved pharmacokinetics and delivery performance.

On Tuesday, President Trump signed an executive order that establishes federal government oversight over some AI models. The order seeks to give the Commerce, Defense, Homeland Security and Treasury departments the leeway to conduct cyber capability assessments of advanced AI models before they are made available to the public.

Australia is making major strides in its transition to renewables thanks to surging household battery capacity . Due to the intermittent nature of clean sources of energy like solar and wind, energy storage has always been key to a proper renewable transition.

The FBI has announced the seizure of roughly $8 billion in crypto and the arrest of hundreds linked to large-scale online fraud networks operating across several continents. Officials say the effort focused on dismantling “scam compounds” linked to organized crime groups, including the Democratic Karen Benevolent Army (DKBA).

Ford is preparing for a major step in its electric vehicle journey with plans to bring back the Escape as an all-electric model in 2029. Although the current gasoline-powered Escape is expected to leave production after the 2026 model year, reports suggest that the popular nameplate will return later in the decade with a completely new identity.

TechMediaWire Editorial Coverage : The U.S. housing market continues grappling with mounting affordability concerns and a persistent lack of available homes, challenges that conventional construction methods have struggled to alleviate. Limited housing inventory remains a major issue across much of the country, while elevated mortgage rates, labor shortages and rising material expenses continue to place homeownership beyond reach for many individuals and families. Industry analysts estimate that millions of additional homes are required to satisfy existing demand, with the shortage impacting urban, suburban and rural communities alike. As affordability concerns deepen, attention is increasingly turning toward faster and more scalable construction alternatives. Factory-built and modular housing systems are gaining traction as viable solutions because they may reduce build times and improve operational efficiency. Within this evolving landscape, BOXABL ( Profile ) has appeared with a strategy centered on manufacturing foldable, factory-built homes capable of being transported efficiently and rapidly assembled on-site. The company, which has entered into a definitive merger agreement with FG Merger II Corp. (NASDAQ: FGMC), is establishing itself where housing innovation, advanced manufacturing and scalable residential development intersect. As demand for affordable housing options continues expanding, BOXABL’s business model reflects a broader movement toward modernizing residential construction and delivery systems. BOXABL joins a group of major players — including D.R. Horton Inc. (NYSE: DHI), Lennar Corporation (NYSE: LEN), Installed Building Products Inc. (NYSE: IBP) and Procore Technologies Inc. (NYSE: PCOR) — focused on residential or commercial construction, housing demand and large-scale building solutions, including automation…

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

BOXABL was featured in a TechMediaWire editorial examining how factory-built housing, automation and advanced manufacturing technologies are emerging as potential solutions to the nation’s housing affordability and supply challenges. The article highlights BOXABL’s foldable, factory-built housing platform, its proposed business combination with FG Merger II Corp. (NASDAQ: FGMC), and the company’s efforts to apply scalable manufacturing principles to residential construction as demand for affordable housing continues to outpace supply.

FingerMotion (NASDAQ: FNGR) announced plans to enter into a memorandum of understanding with BlueFlare Energy Solutions Inc. to develop behind-the-meter artificial intelligence and high-performance computing infrastructure across Alberta, British Columbia and Saskatchewan. Under the proposed framework, BlueFlare would serve as FingerMotion’s primary development partner for site origination, engineering, construction and operations of natural gas-powered AI inference facilities integrated with co-located bitcoin mining operations. The collaboration supports FingerMotion’s strategy of building modular AI and HPC capacity powered by on-site natural gas generation, which the company believes could provide greater control over energy costs and long-term power availability. The parties have identified two initial project sites for evaluation and intend to pursue site-specific agreements as they advance development opportunities in Western Canada.

Kairos Pharma (NYSE American: KAPA) provided a mid-year 2026 update highlighting plans to expand its oncology pipeline through the proposed acquisition of worldwide rights to CL-741, a Phase 1-ready oral c-MET kinase inhibitor from Celyn Therapeutics targeting EGFR-mutated lung cancer and other cancers. The company said CL-741 would complement its existing portfolio, which includes ENV-105, KROS-201, KROS-102 and ENV-205. Looking ahead, Kairos expects to initiate a Phase 1 study of CL-741, advance ongoing clinical trials of ENV-105 in prostate cancer and non-small cell lung cancer, present data at scientific meetings and pursue pharmaceutical collaborations. The company also noted it has secured more than $8 million in non-dilutive funding to support development of its preclinical and clinical programs.

BOXABL announced that FGMC stockholders will vote June 9, 2026, on the proposed business combination that would take BOXABL public. FGMC is encouraging stockholders to vote in favor of the transaction and noted that public stockholders who do not redeem their shares will automatically become BOXABL stockholders upon closing. Following completion of the merger, FGMC is expected to be renamed BOXABL, Inc. and re-list on Nasdaq under the ticker symbol “BXBL.” The deadline for public stockholders to exercise redemption rights is June 5, 2026, at 5 p.m. ET.

Regenerative medicine has long promised to transform patient care, but investors often become most interested when innovative science begins transitioning toward commercial adoption. Regentis Biomaterials (NYSE American: RGNT) is approaching that transition with GelrinC(R), its cartilage regeneration platform targeting a large orthopedic market where treatment alternatives continue to involve meaningful trade-offs. The opportunity is significant. Approximately 470,000 cases of focal knee cartilage damage are treated annually in the United States, yet physicians still lack a broadly available FDA-approved off-the-shelf regenerative cartilage repair solution. For investors, the central question may be straightforward: what happens if a company successfully introduces a simple regenerative solution into a market where no directly comparable option currently exists?

Tesla Inc. (NASDAQ: TSLA) is among the established leaders in utility-scale energy storage, a market drawing increased attention after Ford Motor Company’s announcement that it will invest approximately $2 billion to repurpose former EV battery manufacturing capacity for large-scale energy storage systems. The move sparked Ford’s strongest daily stock rally in nearly six years as investors embraced the company’s effort to tap growing demand from AI data centers, utilities and industrial customers seeking reliable power solutions. Through its Ford Energy subsidiary, Ford aims to begin production in 2027 with annual capacity exceeding 20 gigawatt hours, positioning itself to compete in a rapidly expanding market where energy storage is becoming increasingly critical to supporting AI infrastructure and grid modernization.

GlobalTech (OTC: GLTK) provided a shareholder update outlining its strategy to build a technology-centric holding company through disciplined capital allocation, operational execution and responsible innovation. The company highlighted its focus on combining established operating businesses with scalable technology platforms supported by its AI and Big Data Center of Excellence, while emphasizing commercialization, governance, compliance and long-term value creation. Among key developments, Globaltech cited its acquisition of a 51% controlling interest in Moda in Pelle, continued development of its Cadnz, ThrivoAI and Baseball Blitz platforms, leadership additions and balance sheet improvements through capital raises completed in 2025.

Earth Science Tech (OTC: ETST) announced that Chief Executive Officer and Chairman Giorgio R. Saumat will present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026, at the Bellagio Resort & Hotel in Las Vegas. The presentation will include a live question-and-answer session with attendees.

Oncotelic Therapeutics (OTCQB: OTLC) and Sapu Nano announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) and the appointment of Global Clinical Trials (GCT) as the lead contract research organization for international execution of Study SP-03-B101. The move follows recent regulatory approvals supporting study expansion and marks the transition of the Sapu003 program from an Australia-based clinical effort toward a broader multinational development strategy, including planned expansion into Europe.

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

Trident Digital Tech Holdings (NASDAQ: TDTH) announced the launch of TDTHAI, an artificial intelligence platform designed to support enterprise AI deployment, workflow automation, intelligent service delivery and digital transformation across the Asia-Pacific region. The company said the platform represents a key milestone in its evolution toward an AI-enabled digital infrastructure ecosystem spanning artificial intelligence, cybersecurity, digital identity, government technology, digital commerce and transaction-driven service platforms.

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced definitive agreements with accredited investors for a registered direct offering expected to generate approximately $16.6 million in gross proceeds. The offering consists of 2,625,362 shares of common stock and pre-funded warrants priced at $6.31 per share, with the transaction priced at the market under Nasdaq rules. The company said the financing materially strengthens its balance sheet and provides additional flexibility to pursue strategic priorities.

TransCode Therapeutics (NASDAQ: RNAZ) announced additional results from its Phase 1a dose-escalation trial evaluating TTX-MC138, an investigational microRNA-10b inhibitor for advanced cancer. The study met its primary safety endpoint, with no dose-limiting toxicities observed across 16 patients who received a total of 86 doses. The company reported durable disease stabilization in multiple patients, including three participants who remain on treatment after 14, 16 and 21 cycles, supporting advancement of TTX-MC138 into Phase 2a clinical development.

The price of gold recorded some gains on Tuesday as yields on U.S. Treasuries eased and there was news of de-escalation in the conflict between Israel and Hezbollah in Lebanon. However, there were mixed signals on progress in talks between Iran and the U.S.

Rail Vision (NASDAQ: RVSN, FSE: C80) announced that its AI-powered ShuntingYard system has been integrated into Railserve’s newly introduced YardGUARD industrial railyard safety system, serving as a core technology within the WatchGUARD situational awareness and obstacle detection solution. The integration follows the companies’ recently announced memorandum of understanding and combines Rail Vision’s perception technology with communications and cloud-based monitoring capabilities to provide real-time visibility, obstacle detection, synchronized alerts and automatic braking support. The ShuntingYard system is being showcased this week at Railway Interchange 2026 in Omaha, Nebraska, as part of Railserve’s broader yard safety platform.

Ferrari has always been known for building powerful sports cars with strong engines, exciting performance, and a unique driving experience. For many years, the Italian company has represented luxury, speed, and tradition. However, Ferrari’s decision to introduce its first fully electric vehicle, called the Luce, has created a strong reaction from investors and car enthusiasts around the world.

A new pill can reportedly double survival in early pancreatic cancer trials, raising cautious optimism about a disease that has long resisted treatment. Revolution Medicines’ daraxonrasib targets KRAS, a gene that supplies instructions for the development of the K-Ras protein which is essentially a switch for controlling cell division, growth, and death.

BioMedWire Editorial Coverage: With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure, biotechnology companies are placing greater emphasis on extracting more value from existing therapies through cutting-edge delivery technologies rather than betting solely on the discovery of wholly new compounds. Across the life sciences industry, mounting interest is being directed toward nanoparticle-based platforms, intravenous reformulation strategies and precise pharmacokinetic engineering designed to potentially strengthen bioavailability, systemic exposure, tolerability and dosing reliability of established cancer medicines. Within this broader movement, Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( Profile ) is advancing its Sapu003 program and Deciparticle(TM) platform as key components of a wider industry shift toward scalable nanotechnology-driven drug delivery and AI-enhanced biomedical infrastructure. The company’s approach centers on leveraging platform technologies that may serve multiple therapeutic applications across oncology and rare disease markets rather than depending on a solitary drug candidate. Oncotelic is among several companies, including CytoDyn Inc. (OTCQB: CYDY), Revolution Medicines Inc. (NASDAQ: RVMD), Moderna Inc. (NASDAQ: MRNA) and Sarepta Therapeutics Inc. (NASDAQ: SRPT), that are developing scalable biotechnology platforms designed to support multiple therapeutic programs across diverse disease areas, distinguishing…

This article has been disseminated on behalf of MAX Power Mining Corp. and may include a paid advertisement.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) was featured in a BioMedWire editorial exploring how biotechnology companies are increasingly leveraging advanced drug-delivery technologies, nanotechnology platforms and artificial intelligence to enhance existing therapies and expand treatment opportunities. The article highlights Oncotelic’s Sapu003 program, Deciparticle(TM) platform and PDAOAI initiative as part of a broader industry trend toward scalable, multi-application biotechnology platforms capable of supporting oncology and rare disease programs.

For many investors evaluating companies on the OTC market, share structure often receives as much attention as revenue growth or acquisition activity. Earth Science Tech (OTC: ETST), a strategic holding company spanning telemedicine, pharmacies, clinical support services, and healthcare fulfillment, has increasingly distinguished itself in share structure and financial stability through a sustained program of share repurchases, which has reduced outstanding shares while the company simultaneously expands its healthcare-focused operating platform.

VolitionRx Limited (NYSE American: VNRX) announced the filing of a strategic patent application covering the use of its proprietary Nu.Q technology for triaging and monitoring patients suspected of having contracted the Ebola virus. The application builds on the company’s existing Nu.Q(R) NETs test, which measures circulating nucleosomes and neutrophil extracellular traps as early indicators of hyper-inflammation associated with septic shock and mortality.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Greenland Mines (NASDAQ: GRML) is expanding its position in the critical minerals sector through the advancement of its Skaergaard palladium-gold-platinum project in Greenland and its planned acquisition of the Sarfartoq neodymium-praseodymium (“NdPr”) rare-earths project. According to company disclosures, Skaergaard hosts a substantial palladium-equivalent resource and recently demonstrated significant metal-price leverage in an independent sensitivity study by SLR Consulting, while the Sarfartoq transaction would add an advanced rare-earths asset to the company’s portfolio and establish Neo Performance Materials as a strategic shareholder and future offtake partner.

FingerMotion (NASDAQ: FNGR) announced plans to expand its infrastructure strategy through the development of modular AI-focused edge computing facilities designed to support growing demand for localized artificial intelligence processing and inference workloads. The initiative builds on the company’s existing telecommunications, data and technology operations and is intended to extend its long-term infrastructure and data services roadmap.

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

According to a Reuters report by Hannah Lang and Stefano Rebaudo, with additional reporting by Satoshi Sugiyama, the U.S. dollar traded in a tight range Tuesday as investors monitored developments in ongoing U.S.-Iran negotiations and the potential reopening of the Strait of Hormuz, a key global oil shipping route. Market participants remained cautious amid uncertainty surrounding the conflict and the durability of a ceasefire reached earlier this year between Washington and Tehran.

SOLOWIN HOLDINGS (NASDAQ: AXG) announced that AX Coin Bahrain B.S.C. (c), its stablecoin issuance subsidiary, has received approval from the Central Bank of Bahrain to conduct stablecoin issuer activities. The company said AX Coin is the first entity licensed under the regulator’s stablecoin framework, positioning it among a select group of stablecoin issuers operating under sovereign central bank oversight.

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising.

Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) and other developers of health care AI systems could be affected by proposed Department of Health and Human Services rule changes that would ease longstanding requirements governing the design, testing and transparency of medical software. Supporters argue that reducing mandates for clinician testing and disclosure of training data could accelerate innovation, expand competition and lower costs for hospitals and health systems. Critics, however, warn that weakening safeguards may increase the risk of poorly designed tools entering the market, potentially creating confusion for clinicians, reducing efficiency and increasing the likelihood of medical errors. As policymakers weigh the balance between fostering innovation and protecting patient safety, the debate over how heavily AI-powered health care tools should be regulated is expected to intensify.

Perpetuals.com (NASDAQ: PDC) reported strong early adoption of its UpsideOnly trading and market prediction platform, attracting more than 30,000 active users from 185 countries and generating $4.5 billion in cumulative trading volume across 186,000 fills and 25 instruments during its first two weeks. Gold led activity with $1.4 billion in volume, followed by bitcoin at $1.2 billion, as precious metals accounted for approximately 35% of total platform trading.

Taiwan Semiconductor Manufacturing Company Ltd. (NYSE: TSM) and other semiconductor leaders are benefiting from a powerful AI-driven surge that has sent memory-chip makers such as Micron, Samsung Electronics and SK Hynix to record valuations, fueled by soaring demand for high-bandwidth memory used in data centers supporting artificial intelligence applications. While bullish investors argue that unprecedented spending by hyperscalers including Microsoft, Alphabet and Meta reflects a structural shift in computing demand that differentiates today’s market from past technology bubbles, skeptics warn that the semiconductor sector’s historically cyclical nature and rising debt-funded capital expenditures could signal overheating conditions. As investors weigh whether the rally has further room to run or is approaching a peak, the debate over whether AI enthusiasm is creating the next major market bubble continues to intensify.

Apple Inc. (NASDAQ: AAPL) and other wearable-device developers are positioned to benefit as advances in artificial intelligence and edge computing turn health care wearables into powerful clinical tools capable of delivering real-time, actionable insights rather than overwhelming streams of raw data. By continuously analyzing information collected from patients, AI-powered wearables can help clinicians identify meaningful trends, support remote patient monitoring, improve access to care in underserved areas and reduce the burden on already stretched health care professionals. While challenges remain—including the need for hospitals to modernize systems designed for episodic patient visits—the growing ability of wearables to provide a more complete picture of patient health is creating new opportunities to enhance care delivery and expand the role of connected health technologies.

Uranium Energy (NYSE American: UEC) announced that it will release its fiscal 2026 third quarter operating and financial results before the market opens on June 9, 2026. The company will host a conference call and webcast at 11:00 a.m. ET that same day to discuss the results and provide an update on operations and corporate activities.

Suntex Enterprises (OTC: SNTX) announced the closing of its previously disclosed acquisition of approximately 100 acres in South Texas through its wholly owned subsidiary, Red Spur Land & Ranch Co. Acquired for approximately $2.5 million, the property establishes a strategic land position and serves as the first major deployment of the company’s long-term development platform focused on land ownership, development, construction and infrastructure.

Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how biotechnology companies are increasingly focusing on advanced drug delivery technologies to enhance the effectiveness of existing cancer therapies. The article highlights growing industry interest in nanoparticle delivery systems, intravenous reformulations and precision pharmacokinetic approaches designed to improve bioavailability, systemic exposure, tolerability and dosing consistency.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how biotechnology companies are increasingly focusing on advanced drug delivery technologies to enhance the effectiveness of existing cancer therapies. The article highlights growing industry interest in nanoparticle delivery systems, intravenous reformulations and precision pharmacokinetic approaches designed to improve bioavailability, systemic exposure, tolerability and dosing consistency.

Olenox Industries (NASDAQ: OLOX) reported its first monthly operating update following the acquisition of CS Digital Ventures, announcing production of approximately 18.6 bitcoin during May 2026 and an average operational hashrate of approximately 1.30 EH/s. The company said its mining fleet consists of 9,584 current-generation S21-class ASIC miners representing approximately 35 MW of installed capacity and 2.19 EH/s of nameplate hashrate, with operations currently conducted through third-party hosting facilities drawing power from the ERCOT grid.

Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled defense, security and situational awareness solutions, announced it has received a U.S. Army order for a Threat Analysis Kit that combines its edge-compute NODE platform with Red Cat Holdings’ (NASDAQ: RCAT) Black Widow(TM) drones. The order, awarded through a Defense Prime Contractor subcontract, also includes annual AI model and algorithm software upgrades, training and operational support services, with delivery expected during the second quarter of 2026.

Lantern Pharma (NASDAQ: LTRN), an AI-driven precision oncology company, reported updated Phase 2 HARMONIC trial data showing that LP-300, in combination with carboplatin and pemetrexed, demonstrated a progression-free survival benefit that increased with treatment duration in patients with EGFR Exon 21 L858R-mutant non-small cell lung cancer who had progressed following TKI therapy. The emerging data showed a median progression-free survival of 8.9 months among L858R patients treated through up to six cycles, compared with 8.4 months across the overall L858R cohort, while maintaining what the company described as an exceptionally clean safety and tolerability profile, supporting a recently FDA-cleared protocol amendment extending LP-300 dosing from six to eight cycles.

BOXABL announced its inclusion in an AINewsWire editorial examining how the U.S. housing affordability and supply crisis is driving demand for alternative construction models. The article highlights ongoing challenges including limited housing inventory, rising mortgage rates, labor shortages and increasing construction costs, which have accelerated interest in factory-built and modular housing solutions that can improve efficiency and reduce build times.

Silver has traditionally been viewed alongside gold as a safe-haven asset, attracting investors during inflationary periods and economic uncertainty. Today, however, the market is increasingly being driven by industrial consumption rather than investment demand alone.

Multinational vehicle manufacturer Stellantis has revealed plans to release 29 electric vehicle models by the end of the decade. The company behind some of the world’s largest automakers will go all in on electric vehicle development over the next 5 years to launch over two dozen EV models as part of a strategic plan designed to give Stellantis an edge in the growing electric vehicle industry.

A new viral-based vector that can be inhaled into the lungs could boost the anti-cancer response of the body in patients diagnosed with advanced lung cancer. This new treatment could also restore sensitivity to immune checkpoint inhibitors among patients that had become unresponsive.

OpenAI chief executive officer Sam Altman remarked recently that fears of AI triggering mass unemployment may have been overstated, noting that the technology hasn’t displaced office-based workers as quickly as he once expected.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

The rapid shift of financial services into digital spaces is creating new opportunities for cybercriminals, many of whom are increasingly relying on AI to outsmart security checks. From fabricated identities to altered documents, fraudsters are using advanced tools to bypass verification systems that many financial technology companies still struggle to secure.

Ferrari has officially entered a new chapter in its history after unveiling its first fully electric vehicle, the Luce. The luxury sports car company revealed the new model in Rome, marking a major shift for one of the world’s most famous car brands. Known for powerful gasoline engines and high-performance supercars, Ferrari is now joining the growing electric vehicle market while still trying to maintain the style and performance that made the brand popular worldwide.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

BOXABL announced the launch of a beta online catalog and configurator on its developer webpage, marking a key milestone in the company’s Phase 2 growth strategy. The platform showcases a growing portfolio of residential products and reflects BOXABL’s transition from its initial Casita offering toward a broader housing system designed around standardized manufacturing technology.

American Fusion (OTC: AMFN), a company developing advanced fusion energy technologies, announced the filing of a new patent application covering innovations and design features expected to be incorporated into future commercial versions of its Texatron(TM) Fusion Engine(TM) platform following completion of Version 9 testing. The filing expands the company’s intellectual property portfolio and reflects its ongoing efforts to protect proprietary technologies as the platform advances toward commercial deployment and pre-production system design.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

Gaxos.ai (NASDAQ: GXAI) announced that Amazon Web Services (“AWS”) has committed additional funding to support development of Gaxos Labs’ AI-powered sales coaching platform, strengthening the company’s expansion into the sales technology market and advancing its strategy to build enterprise-grade artificial intelligence applications designed for commercial scalability.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Perpetuals.com (NASDAQ: PDC) reported strong early adoption of its UpsideOnly trading and market prediction platform, attracting more than 30,000 active users from 185 countries and generating $4.5 billion in cumulative trading volume across 186,000 fills and 25 instruments during its first two weeks. Gold led activity with $1.4 billion in volume, followed by bitcoin at $1.2 billion, as precious metals accounted for approximately 35% of total platform trading.

This article has been disseminated on behalf of Search Minerals Inc. and may include paid advertising.